GLSI

Greenwich Lifesciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 2/10
  • Value↑ 5/10
Greenwich Lifesciences sales and earnings growth
GLSI Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -82.50%
  • FCF Y/Y↓ -13.51%
Greenwich Lifesciences gross and profit margin trends
GLSI Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 2315.12%
Greenwich Lifesciences net debt vs free cash flow
GLSI Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Greenwich Lifesciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗